• Citer

Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.

par Jeschke, Jana ;O'Hagan, Heather M;Zhang, Wei;Vatapalli, Rajita;Calmon, Marilia Freitas;Danilova, Ludmila;Nelkenbrecher, Claudia;Van Neste, Leander;Bijsmans, Ingrid IT;van Engeland, Manon;Gabrielson, Edward;Schuebel, Kornel K.E.;Winterpacht, Andreas;Baylin, Stephen B;Herman, James G;Ahuja, Nita
Référence Clinical cancer research, 19, 12, page (3201-3211)
Publication Publié, 2013-06

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines.
Auteur:	Jeschke, Jana; O'Hagan, Heather M; Zhang, Wei; Vatapalli, Rajita; Calmon, Marilia Freitas; Danilova, Ludmila; Nelkenbrecher, Claudia; Van Neste, Leander; Bijsmans, Ingrid IT; van Engeland, Manon; Gabrielson, Edward; Schuebel, Kornel K.E.; Winterpacht, Andreas; Baylin, Stephen B; Herman, James G; Ahuja, Nita
Informations sur la publication:	Clinical cancer research, 19, 12, page (3201-3211)
Statut de publication:	Publié, 2013-06
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Anthracyclines -- administration & dosage
	Breast Neoplasms -- genetics -- metabolism -- pathology
	Cell Line, Tumor
	Cell Proliferation -- drug effects
	Cell Survival -- drug effects
	Cysteine Dioxygenase -- antagonists & inhibitors -- genetics
	DNA Methylation -- genetics
	Drug Resistance, Neoplasm -- genetics -- immunology
	Female
	Gene Silencing
	Humans
	Reactive Oxygen Species -- metabolism
Langue:	Anglais
Identificateurs:	urn:issn:1078-0432
	info:doi/10.1158/1078-0432.CCR-12-3751
	info:pii/1078-0432.CCR-12-3751
	info:pmid/23630167
	PMC3985391